Abstract
A new bacteriocin, lacticin LC14, produced by Lactococcus lactis BMG6.14, was isolated and characterized. It was purified to homogeneity from overnight broth culture by ammonium sulfate precipitation, Sep-Pak chromatography, and two steps of reversed-phase HPLC. Lacticin LC14 showed bactericidal-type antimicrobial activity against several lactic acid bacteria and pathogenic strains including Listeria monocytogenes. It was inactivated by proteinase K and pronase E, but was resistant to papain, lysozyme, lipase and catalase. Lacticin LC14 was heat resistant, stable over a wide range of pH (2-10) and after treatment by solvents and detergents. Its N-terminal end was found unreactive towards Edman sequencing. Based on MALDI-TOF mass spectrometry, its molecular mass was 3333.7 Da. LC14 amino acid composition revealed a high proportion of hydrophobic residues, but no modified ones. LC14 may be able to challenge other well known other bacteriocins in probiotic and therapeutic applications.
Keywords: Antimicrobial activity, Bacteriocin, Lactic acid bacteria, Lacticin LC14, Listeria monocytogenes, Lactococcus lactis subsp. lactis BMG6.14, ammonium sulfate precipitation, chromatography, chromatography, pathogenic strains, lysozyme, lipase and catalase, amino acid, hydrophobic residues
Infectious Disorders - Drug Targets
Title:Lacticin LC14, a New Bacteriocin Produced by Lactococcus lactis BMG6.14: Isolation, Purification and Partial Characterization
Volume: 12 Issue: 4
Author(s): Samar Lasta, Hadda Ouzari, Nicolas Andreotti, Ziad Fajloun, Pascal Mansuelle, Abdellatif Boudabous, François Sampieri and Jean Marc Sabatier
Affiliation:
Keywords: Antimicrobial activity, Bacteriocin, Lactic acid bacteria, Lacticin LC14, Listeria monocytogenes, Lactococcus lactis subsp. lactis BMG6.14, ammonium sulfate precipitation, chromatography, chromatography, pathogenic strains, lysozyme, lipase and catalase, amino acid, hydrophobic residues
Abstract: A new bacteriocin, lacticin LC14, produced by Lactococcus lactis BMG6.14, was isolated and characterized. It was purified to homogeneity from overnight broth culture by ammonium sulfate precipitation, Sep-Pak chromatography, and two steps of reversed-phase HPLC. Lacticin LC14 showed bactericidal-type antimicrobial activity against several lactic acid bacteria and pathogenic strains including Listeria monocytogenes. It was inactivated by proteinase K and pronase E, but was resistant to papain, lysozyme, lipase and catalase. Lacticin LC14 was heat resistant, stable over a wide range of pH (2-10) and after treatment by solvents and detergents. Its N-terminal end was found unreactive towards Edman sequencing. Based on MALDI-TOF mass spectrometry, its molecular mass was 3333.7 Da. LC14 amino acid composition revealed a high proportion of hydrophobic residues, but no modified ones. LC14 may be able to challenge other well known other bacteriocins in probiotic and therapeutic applications.
Export Options
About this article
Cite this article as:
Lasta Samar, Ouzari Hadda, Andreotti Nicolas, Fajloun Ziad, Mansuelle Pascal, Boudabous Abdellatif, Sampieri François and Marc Sabatier Jean, Lacticin LC14, a New Bacteriocin Produced by Lactococcus lactis BMG6.14: Isolation, Purification and Partial Characterization, Infectious Disorders - Drug Targets 2012; 12 (4) . https://dx.doi.org/10.2174/187152612801319276
DOI https://dx.doi.org/10.2174/187152612801319276 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Flow-Injection Potentiometric Method for the Routine Determination of Chloride: Application to Bread Analysis
Current Analytical Chemistry Withdrawal Notice: Neuroprotective Effect of Lithospermum officinale callus Extract on Inflamed Primary Microglial Cells
Current Pharmaceutical Biotechnology LiSIs: An Online Scientific Workflow System for Virtual Screening
Combinatorial Chemistry & High Throughput Screening Cell Division Cycle 25 (Cdc25) Phosphatase Inhibitors as Antitumor Agents
Drug Design Reviews - Online (Discontinued) Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) Novel Somatic Mutations of the CDH1 Gene Associated with Gastric Cancer: Prediction of Pathogenicity Using Comprehensive In silico Methods
Current Pharmacogenomics and Personalized Medicine Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?
Current Topics in Medicinal Chemistry Approaches for the Development of New Anti-Trypanosoma cruzi Agents
Current Drug Targets Functional Genomics and NMR Spectroscopy
Combinatorial Chemistry & High Throughput Screening Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent
Current Topics in Medicinal Chemistry Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology New Developments in Targeted Analysis of Protein Posttranslational Modifications
Current Proteomics A Study on Identification of Nutraceutical Value of New Imidazolone Schiff Base Analogues
Letters in Drug Design & Discovery Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Ganoderma lucidum: A Source for Novel Bioactive Lectin
Protein & Peptide Letters Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies
Current Drug Therapy Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design
Current Medicinal Chemistry Fungal Pathogens Research: Novel and Improved Molecular Approaches for the Discovery of Antifungal Drug Targets
Current Drug Targets Recent Progress on Bioinformatics, Functional Genomics, and Metabolomics Research of Cytochrome P450 and its Impact on Drug Discovery
Current Topics in Medicinal Chemistry Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals
Current Drug Delivery